Newsroom

WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca’s ETCAMAH® (camizestrant) in combination with a cyclin-dependent kinase (CDK) 4/6 inhibitor (abemaciclib, palbociclib or ribociclib) has been approved in the US for the treatment of adult patients with hormone receptor (HR)-positive, HER2-negative, locally advanced or metastatic breast cancer upon detection of ESR1 mutation during aromatase inhibitor (AI) and CDK4/6 inhibitor therapy, based on a US Food and Drug Administration (FDA)-authorized test...

CLEVELAND--(BUSINESS WIRE)--ErieView Development today announced the closing of financing for the $218 million conversion of Erieview Tower — turning the 40-story 1964 landmark at East Ninth Street and St. Clair Avenue into the 210-key W Cleveland hotel, expected to be the first W Hotel in Ohio, and 215 W Apartments offered for rent rather than for sale, a first for the brand worldwide. The hotel and residences are scheduled to open around late 2027. The amenity program is the most extensive as...

BALL GROUND, Ga.--(BUSINESS WIRE)--Ameribrands, a diversified platform of specialized businesses serving the restaurant, retail, hospitality, entertainment, education and facilities sectors, recently announced the acquisition of Randal Retail Group, a leading provider of retail design, fixture manufacturing, merchandising displays and installation services. The acquisition significantly strengthens Ameribrands’ retail capabilities and advances its strategy of building a premier national platfor...

ROSWELL, Ga.--(BUSINESS WIRE)--Eirion Risk Underwriters launches an Inland Marine program: broad appetite, up to $25M capacity, and direct underwriter access....

PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that the U.S. Food and Drug Administration (FDA) has approved Guardant360® CDx as a companion diagnostic (CDx) to identify patients with hormone receptor (HR)-positive, HER2-negative advanced or metastatic breast cancer harboring tumors with ESR1 mutations before radiographic progression who may benefit from treatment with ETCAMAH™ (camizestrant), AstraZeneca’s next-gener...

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF continues its investigation into Acadia Healthcare Company, Inc. (NasdaqGS: ACHC).On September 27, 2024, the Company disclosed the receipt of a voluntary request for information from the U. S. Attorney’s Office for the Southern District of New York as well as a grand jury subpoena from the United States District Court...

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds investors that a securities class action has been filed on behalf of all persons and entities that purchased or otherwise acquired Planet Fitness, Inc. (NYSE: PLNT) common stock between November 6, 2025 and May 5, 2026, inclusive (the "Class Period"). The lawsuit alleges that Planet Fitness made materially false or misleading statements regarding its membership growth, marketing strategy, pricing initiatives, and long-term financial outlook. Inves...

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP reminds investors that a class action was filed on behalf of all purchasers of The Simply Good Foods Company (NASDAQ: SMPL) common stock between October 24, 2024 and April 8, 2026 (the "Class Period"). Good Foods sells consumer packaged foods and snacking products under its various brands. The complaint alleges that Good Foods misled investors regarding the successful integration of OWYN. Investors who suffered significant loss...

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF continues its investigation into Humacyte, Inc. (NasdaqGS: HUMA) (“Humacyte” or the “Company”). On August 9, 2024, the company announced that the Food and Drug Administration (“FDA”) “will require additional time to complete its review of its Biologic License Application (BLA) for the acellular tissue engin...

NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF continues its investigation into The Scotts Miracle-Gro Company (NYSE: SMG) (“Scotts” or the “Company”). On August 2, 2023, the Company disclosed disappointing financial results including a decline in quarterly sales for fiscal third quarter of 6%, a decline in gross margin by 420 basis points, as well...